Edition:
United Kingdom

Swedish Orphan Biovitrum AB (publ) (SOBIV.ST)

SOBIV.ST on Stockholm Stock Exchange

179.60SEK
22 May 2018
Change (% chg)

-2.40kr (-1.32%)
Prev Close
182.00kr
Open
182.00kr
Day's High
185.00kr
Day's Low
172.15kr
Volume
1,514,158
Avg. Vol
866,921
52-wk High
194.75kr
52-wk Low
107.40kr

Select another date:

Mon, Feb 26 2018

BRIEF-Sobi appoints Henrik Stenqvist as new CFO

* HENRIK STENQVIST IS JOINING SOBI AS NEW CHIEF FINANCIAL OFFICER

BRIEF-Swedish Orphan Biovitrum says receives positive opinion from CHMP on Anakira

* The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for Anakinra for the treatment of Still’s disease.

UPDATE 1-‍Sobi Q4 tops forecast but 2018 outlook below market expectations​

Feb 22 Rare-disease drug maker Swedish Orphan Biovitrum (Sobi) reported on Thursday a bigger fourth-quarter profit jump than expected but guided for slightly slower profit growth in 2018 than estimated by analysts.

BRIEF-‍Sobi Q4 core profit beats expectations ​

* SAYS ‍SOBI EXPECTS TOTAL REVENUES FOR FULL-YEAR TO BE IN RANGE OF SEK 7,500 - 7,700 M.​

Select another date: